IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 175 filers reported holding IMMUNOMEDICS INC in Q1 2018. The put-call ratio across all filers is 0.81 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $7,270,000 | +13.1% | 524,140 | +56.6% | 6.06% | -22.4% |
| Q1 2019 | $6,430,000 | -49.6% | 334,724 | -62.6% | 7.80% | +48.3% |
| Q4 2018 | $12,767,000 | -56.2% | 894,679 | -36.0% | 5.26% | -5.7% |
| Q3 2018 | $29,132,000 | -7.4% | 1,398,577 | +5.2% | 5.58% | +14.6% |
| Q2 2018 | $31,460,000 | +99.1% | 1,329,104 | +22.9% | 4.87% | +87.2% |
| Q1 2018 | $15,799,000 | +141.7% | 1,081,410 | +167.3% | 2.60% | +115.9% |
| Q4 2017 | $6,537,000 | -41.0% | 404,528 | -48.9% | 1.20% | -57.7% |
| Q3 2017 | $11,074,000 | +169.7% | 792,106 | -37.3% | 2.85% | +12.9% |
| Q3 2016 | $4,106,000 | – | 1,263,276 | – | 2.52% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 1,711,067 | $2,943,000 | 1.70% |
| J.P. Turner & Co Capital Mnagement, LLC | 248,625 | $428,000 | 0.44% |
| Orbimed Advisors | 3,323,000 | $5,716,000 | 0.06% |
| BALYASNY ASSET MANAGEMENT L.P. | 2,004,078 | $3,447,000 | 0.02% |
| WOLVERINE ASSET MANAGEMENT LLC | 5,870 | $1,018,000 | 0.02% |
| SIGNET FINANCIAL MANAGEMENT, LLC | 44,675 | $77,000 | 0.02% |
| SVB WEALTH LLC | 195,000 | $335,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 288,900 | $497,000 | 0.01% |
| J.P. Turner & Co Capital Mnagement, LLC | 153,900 | $8,000 | 0.01% |
| BALYASNY ASSET MANAGEMENT L.P. | 640,400 | $1,101,000 | 0.01% |